BioStock: Neola’s rapid development recognised at JPMorgan

The 42nd edition of the JPMorgan Health Conference took place last week, and one of the participants was Neola Medical. The Swedish medtech is currently preparing its lung monitoring system for a clinical study in the US. BioStock spoke to the company’s CEO Hanna Sjöström to get her impressions from the conference.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/01/neolas-rapid-development-recognised-at-jpmorgan/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se